Rose Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Think FDA Inspections Are Painful Now? These Could Be The Good Old Days

Executive Summary

ICMAD's recent regulatory workshop offered perspective from FDA's Linda Katz and industry experts on the inspection process for cosmetics facilities under current law. It's clear that FDA inspections can be an ordeal, but that would pale in comparison to challenges that could arise under the proposed Personal Care Products Safety Act.


Related Content

FDA Inspection Photography: Pick Your Battles, Cover Your Bases
FDA Warning Letter Renews Concerns About Barring Inspection Photos
Former FDA Commish Califf Advocates Cosmetics Registration, AE Reporting
Cosmetics Reform Bill Relaunches In Senate, Sending Stakeholders To Familiar Corners
ICMAD Clutches To House Cosmetics Bill Before Specter Of ‘Activist FDA’
House Cosmetics Bill Reintroduced; ICMAD Optimistic In New Political Climate
‘Ant-type Insects’ And Expired Ingredients: FDA Warns Bioque Following Inspection
FDA’s Candid Overview Of Cosmetics Regime Signals Support For Reform Bill
FDA Warning Letter Depicts Personal-Care Regulation's Present, Possible Future
Jan Marini Focused On Damage Control Following FDA Seizure Of Eyelash Item





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts